Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
USANA Health ( (USNA) ) has issued an announcement.
On June 27, 2025, USANA Health Sciences, Inc. entered into a Third Amended and Restated Credit Agreement with Bank of America, providing a revolving credit limit of up to $75 million, with an option to increase by $200 million. This agreement is secured by the pledge of capital stock of USANA’s subsidiaries and includes financial covenants related to EBITDA and debt ratios. The agreement allows for flexibility in financial operations, as it does not restrict cash dividends or share repurchases, but outlines events of default that could lead to immediate repayment demands.
The most recent analyst rating on (USNA) stock is a Hold with a $65.00 price target. To see the full list of analyst forecasts on USANA Health stock, see the USNA Stock Forecast page.
Spark’s Take on USNA Stock
According to Spark, TipRanks’ AI Analyst, USNA is a Outperform.
USANA Health’s stock is buoyed by strong earnings growth and proactive strategic initiatives, as highlighted in the latest earnings call. While technical indicators show positive momentum, financial performance is stable but challenged by declining revenues and net margins. Valuation metrics suggest the stock is fairly priced, making it an attractive investment in the packaged foods sector.
To see Spark’s full report on USNA stock, click here.
More about USANA Health
Average Trading Volume: 194,145
Technical Sentiment Signal: Sell
Current Market Cap: $579.7M
For an in-depth examination of USNA stock, go to TipRanks’ Overview page.